Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial

Transplant Proc. 2001 May;33(3):2330-1. doi: 10.1016/s0041-1345(01)02011-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Azathioprine / therapeutic use
  • Bacterial Infections / epidemiology
  • Cytomegalovirus Infections / epidemiology
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Liver Transplantation / physiology
  • Muromonab-CD3 / therapeutic use
  • Mycoses / epidemiology
  • Postoperative Complications / epidemiology
  • Prednisolone / therapeutic use
  • Prospective Studies
  • Sepsis / epidemiology
  • Survival Rate
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*
  • Time Factors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Prednisolone
  • Azathioprine
  • Tacrolimus